🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Adult acute lymphoblastic leukemia treatment approaches relie on risk strat...
Status
Unknown
Location
CRLCC Centre Paul Papin
Start Date
2003-11
Trial ID
NCT00188084
Treatments Being Tested
This diagnostic trial is studying the presence of a specific protein as a p...
Status
Completed
Location
Gynecologic Oncology Group of Arizona
Start Date
1998-09
Trial ID
NCT00003384
Treatments Being Tested
Epidemiological evidence shows that adverse experiences, particularly, but ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT06386380
Treatments Being Tested
This study compares changes in P16INK4A expression and plasma proteomic sig...
Status
Recruiting
Location
University of North Carolina
Start Date
2024-10-10
Trial ID
NCT06789653
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
Cyclin kinase inhibitor P16INK4A has overexpression in cervical cancer, and...
Status
Unknown
Location
Lei Li
Start Date
2020-11-26
Trial ID
NCT04650711
Treatments Being Tested
P16 is a tumor suppressor protein implicated in serous papillary endometria...
Status
Completed
Location
Rambam Medical Center
Start Date
2010-07
Trial ID
NCT01267357
Treatments Being Tested
Ovarian germ cell tumors (OGCTs) constitute 10% of ovarian tumors in Egypt ...
Status
Completed
Location
Assiut University
Start Date
2019-12-24
Trial ID
NCT04283773
MiST is a British Lung Foundation funded, University of Leicester Study, a ...
Status
Completed
Location
University Hospitals of Leicester NHS Trust
Start Date
2019-01-28
Trial ID
NCT03654833